About the Authors
- Ruxandra Schiotis
- Department of Pharmacology, “Iuliu Hatieganu” University of Medicine and Pharmacy and SCBI- Rheumatology Department, Cluj-Napoca, Romania
- Ruxandra Schiotis, Eduardo Collantes Estevez
- Department of Rheumatology, University Hospital “Reina Sofía”/IMIBIC, Córdoba, Spain
- Nerea Bartolomé, Magdalena Szczypiorska, Antonio Martínez, Diego Tejedor, Marta Artieda
- Department of R+D, Progenika Biopharma SA, Derio-Vizcaya, Spain
- Alejandra Sánchez, Jesús Sanz, Juan Mulero
- Department of Rheumatology, “Puerta de Hierro Majadahonda”, University Hospital, Madrid, Spain
- Eduardo Cuende
- Department of Rheumatology, University Hospital “Príncipe de Asturias”, Alcalá de Henares, Madrid, Spain
- Anca Buzoianu
- Department of Pharmacology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
The authors declare the following interests: M.S., N.B., M.A., A.M. and D.T. are currently employees of Progenika Biopharma, SA. A.S. is supported by an unrestricted grant from Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared no conflicts of interest.
Conceived and designed the experiments: RS AS JS ECE AB JM. Performed the experiments: NB MS AM DT MA. Analyzed the data: RS NB AS MS DT MA ECE JM. Contributed reagents/materials/analysis tools: AS ECE JM JS EC AB. Wrote the paper: RS AS NB ECE JM.